Dual Delivery of Hepatocyte and Vascular Endothelial Growth Factors via a Protease-Degradable Hydrogel Improves Cardiac Function in Rats

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Salimath, Apoorva S ^a,b   Phelps, Edward A ^a,b   Boopathy, Archana V ^a,c   Che, Pao lin ^a,c   Brown, Milton ^a,c   García, Andrés J ^a,b   Davis, Michael E ^a,c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; MACROGOL; SCATTER FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL REGENERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART INFARCTION; HEART VENTRICLE REMODELING; HEMODYNAMICS; HYDROGEL; INFLAMMATION; LIVER CELL; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL MOVEMENT; CELL SEPARATION; DRUG DELIVERY SYSTEMS; FIBROSIS; HEART; HEMODYNAMICS; HEPATOCYTE GROWTH FACTOR; HYDROGEL; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HARNESS; RATTUS;

EID: 84870577591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050980     Document Type: Article

References (54)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220.
2. Almeda FQ, Snell RJ, Parrillo JE, (2001) The contemporary management of acute myocardial infarction. Crit Care Clin 17: 411-434.
3. Anversa P, (2000) Myocyte death in the pathological heart. Circ Res 86: 121-124.
4. Anversa P, Di Somma S, Bianchi G, Li B, Kajstura J, et al. (1995) Cellular mechanisms of cardiac failure in the infarcted heart. Cardiologia 40: 909-920.
5. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, et al. (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107.
6. Anversa P, Leri A, Kajstura J, (2006) Cardiac regeneration. J Am Coll Cardiol 47: 1769-1776.
7. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, et al. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355: 1222-1232.
8. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363: 751-756.
9. Sy JC, Davis ME, (2010) Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers. J Cardiovasc Transl Res 3: 461-468.
10. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, et al. (2006) Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 103: 8155-8160.
11. Engel FB, Hsieh PC, Lee RT, Keating MT, (2006) FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci U S A 103: 15546-15551.
12. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT, (2006) Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 116: 237-248.
13. Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, et al. (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113: 516-527.
14. Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, et al. (2000) Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol 35: 1323-1330.
15. Epstein SE, Kornowski R, Fuchs S, Dvorak HF, (2001) Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104: 115-119.
16. Phelps EA, Enemchukwu NO, Fiore VF, Sy JC, Murthy N, et al. (2012) Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv Mater 24: 64-70, 62.
17. Patterson J, Hubbell JA, (2010) Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials 31: 7836-7845.
18. Patterson J, Hubbell JA, (2011) SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels. Biomaterials 32: 1301-1310.
19. Sy JC, Seshadri G, Yang SC, Brown M, Oh T, et al. (2008) Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater 7: 863-868.
20. French KM, Boopathy AV, Dequach JA, Chingozha L, Lu H, et al. (2012) A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro. Acta Biomater.
21. Leri A, Quaini F, Kajstura J, Anversa P, (2001) Myocyte death and myocyte regeneration in the failing human heart. Ital Heart J 2Suppl 3: 12S-14S.
22. Phelps EA, Landazuri N, Thule PM, Taylor WR, Garcia AJ, (2010) Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci U S A 107: 3323-3328.
23. Danielsen CC, Wiggers H, Andersen HR, (1998) Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J Mol Cell Cardiol 30: 1431-1442.
24. Ifkovits JL, Tous E, Minakawa M, Morita M, Robb JD, et al. (2010) Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A 107: 11507-11512.
25. Wall ST, Yeh CC, Tu RY, Mann MJ, Healy KE, (2010) Biomimetic matrices for myocardial stabilization and stem cell transplantation. J Biomed Mater Res A 95: 1055-1066.
26. Jacot JG, Dianis S, Schnall J, Wong JY, (2006) A simple microindentation technique for mapping the microscale compliance of soft hydrated materials and tissues. J Biomed Mater Res A 79: 485-494.
27. Jacot JG, Kita-Matsuo H, Wei KA, Chen HS, Omens JH, et al. (2010) Cardiac myocyte force development during differentiation and maturation. Ann N Y Acad Sci 1188: 121-127.
28. Jacot JG, McCulloch AD, Omens JH, (2008) Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 95: 3479-3487.
29. Nakagawa K, Chen YX, Ishibashi H, Yonemitsu Y, Murata T, et al. (2000) Angiogenesis and its regulation: roles of vascular endothelial cell growth factor. Semin Thromb Hemost 26: 61-66.
30. Kloner RA, Dow J, Chung G, Kedes LH, (2000) Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model. J Thromb Thrombolysis 10: 285-289.
31. Cho KR, Choi JS, Hahn W, Kim DS, Park JS, et al. (2008) Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model. Eur J Cardiothorac Surg 34: 857-863.
32. Morishita R, Aoki M, Hashiya N, Yamasaki K, Kurinami H, et al. (2004) Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 4: 199-206.
33. Ruvinov E, Leor J, Cohen S, (2010) The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials 31: 4573-4582.
34. Yamaguchi T, Sawa Y, Miyamoto Y, Takahashi T, Jau CC, et al. (2005) Therapeutic angiogenesis induced by injecting hepatocyte growth factor in ischemic canine hearts. Surg Today 35: 855-860.
35. Siltanen A, Kitabayashi K, Lakkisto P, Makela J, Patila T, et al. (2011) hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure. PLoS One 6: e19161.
36. Zhu XY, Zhang XZ, Xu L, Zhong XY, Ding Q, et al. (2009) Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue. Biochem Biophys Res Commun 379: 1084-1090.
37. Miyagawa S, Sawa Y, Fukuda K, Hisaka Y, Taketani S, et al. (2006) Angiogenic gene cell therapy using suicide gene system regulates the effect of angiogenesis in infarcted rat heart. Transplantation 81: 902-907.
38. Ruvinov E, Leor J, Cohen S, (2011) The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32: 565-578.
39. Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, et al. (2011) Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 30: 95-102.
40. Fatma S, Selby DE, Singla RD, Singla DK, (2010) Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization. Antioxid Redox Signal 13: 1857-1865.
41. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, et al. (2008) Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 10: 1065-1072.
42. Chen RR, Silva EA, Yuen WW, Mooney DJ, (2007) Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24: 258-264.
43. Sun Q, Silva EA, Wang A, Fritton JC, Mooney DJ, et al. (2010) Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm Res 27: 264-271.
44. Saif J, Schwarz TM, Chau DY, Henstock J, Sami P, et al. (2010) Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol 30: 1897-1904.
45. Samuel SM, Akita Y, Paul D, Thirunavukkarasu M, Zhan L, et al. (2010) Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes 59: 51-60.
46. Zentilin L, Puligadda U, Lionetti V, Zacchigna S, Collesi C, et al. (2010) Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J 24: 1467-1478.
47. Wang Y, Ahmad N, Wani MA, Ashraf M, (2004) Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol 37: 1041-1052.
48. Vilahur G, Juan-Babot O, Pena E, Onate B, Casani L, et al. (2011) Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol 50: 522-533.
49. Tang J, Wang J, Kong X, Yang J, Guo L, et al. (2009) Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp Cell Res 315: 3521-3531.
50. Linke A, Muller P, Nurzynska D, Casarsa C, Torella D, et al. (2005) Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 102: 8966-8971.
51. Chimenti I, Rizzitelli G, Gaetani R, Angelini F, Ionta V, et al. (2011) Human cardiosphere-seeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs. Biomaterials 32: 9271-9281.
52. Xaymardan M, Cimini M, Fazel S, Weisel RD, Lu WY, et al. (2009) c-Kit function is necessary for in vitro myogenic differentiation of bone marrow hematopoietic cells. Stem Cells 27: 1911-1920.
53. Kadner K, Dobner S, Franz T, Bezuidenhout D, Sirry MS, et al. (2012) The beneficial effects of deferred delivery on the efficiency of hydrogel therapy post myocardial infarction. Biomaterials 33: 2060-2066.
54. Rane AA, Chuang JS, Shah A, Hu DP, Dalton ND, et al. (2011) Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One 6: e21571.